Anne Cox is the Director of Business Development at Tensentric, where she works with clients to understand the cross section of clinical need, biochemical constraints, and the maximal value that custom engineering, human factors, and manufacturing solutions could deliver in bringing promising technology from bench to bedside. Anne has a B.S. in Chemical and Biological Engineering and a background as a project engineer & manager at Tensentric on a variety of cell & gene therapy, life sciences, and in-vitro diagnostic systems, including the implementation of Tensentric’s cell culture lab. She also serves on the Industry Advisory Board for the Biomedical Engineering program at the University of Colorado, Boulder.
Also Speaking
Andrew Olaye
Executive Director, Market Access & Partnerships EMEA • Orchard Therapeutics
15 November 2022
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023